Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
1.
Public Health ; 213: 1-4, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36308872

ABSTRACT

OBJECTIVES: This study aimed to study the public's sentiments on the current monkeypox outbreaks via an unsupervised machine learning analysis of social media posts. STUDY DESIGN: This was an exploratory analysis of tweets sentiments. METHODS: We extracted original tweets containing the terms 'monkeypox', 'monkey pox' or 'monkey_pox' and posted them in the English language from 6 May 2022 (first case detected in the United Kingdom) to 23 July 2022 (when World Health Organization declared Monkeypox to be a global health emergency). Retweets and duplicate tweets were excluded from study. Bidirectional Encoder Representations from Transformers (BERT) Named Entity Recognition. This was followed by topic modelling (specifically BERTopic) and manual thematic analysis by the study team, with independent reviews of the topic labels and themes. RESULTS: Based on topic modelling and thematic analysis of a total of 352,182 Twitter posts, we derived five topics clustered into three major themes related to the public discourse on the ongoing outbreaks. These include concerns of safety, stigmatisation of minority communities, and a general lack of faith in public institutions. The public sentiments underscore growing (and existing) partisanship, personal health worries in relation to the evolving situation, as well as concerns of the media's portrayal of lesbian, gay, bisexual, transgender and queer and minority communities, which might further stigmatise these groups. CONCLUSIONS: Monkeypox is an emerging infectious disease of public concern. Our study has highlighted important societal issues, including misinformation, political mistrust and anti-gay stigma that should be sensitively considered when designing public health policies to contain the ongoing outbreaks.


Subject(s)
Minority Groups , Unsupervised Machine Learning , Humans , Animals , Public Policy , Haplorhini , United Kingdom/epidemiology
2.
J Hosp Infect ; 130: 95-103, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36116538

ABSTRACT

BACKGROUND: In the wake of the coronavirus disease 2019 (COVID-19) pandemic, demand for deep cleaning and environmental services workers grew exponentially. Although there is extant literature examining the impact of the COVID-19 pandemic on healthcare workers, less emphasis has been placed on environmental services workers, who play an equally important front-line role. AIM: To examine the impact of the COVID-19 pandemic on environmental services workers employed in healthcare settings. METHODS: Scoping review methodology. A search strategy was developed, in consultation with a medical information specialist, employing various combinations of the keywords [(environmental services worker OR health attendant OR housekeeping) AND (COVID OR coronavirus OR pandemic OR epidemic)]. Four bibliographical databases were searched from inception to 5th July 2022: OVID Medline, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Cochrane Database. RESULTS: In total, 24 studies were included in this review. The studies were generally cross-sectional in design. Seroprevalence studies highlighted significantly higher rates of COVID-19 among environmental services workers (housekeeping, cleaning and janitorial staff) compared with other clinical and non-clinical staff in the same institutions. In addition, based on qualitative interviews, environmental services workers experienced greater psychological stress working during the pandemic. CONCLUSIONS: Environmental services workers were particularly vulnerable to increased work stress and COVID-19 during the pandemic. Health systems need to do more to support these workers. Further research could investigate specific policy and procedural changes to benefit this under-recognized group in the greater healthcare workforce.


Subject(s)
COVID-19 , Humans , COVID-19/epidemiology , Pandemics , Seroepidemiologic Studies , Cross-Sectional Studies , Health Personnel/psychology , Delivery of Health Care
3.
J Eur Acad Dermatol Venereol ; 36(10): 1689-1704, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35766904

ABSTRACT

BACKGROUND: Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or, most frequently, generalized bullous lesions. A subset of patients only develops excoriations, prurigo-like lesions, and eczematous and/or urticarial erythematous lesions. The disease, which is significantly associated with neurological disorders, has high morbidity and severely impacts the quality of life. OBJECTIVES AND METHODOLOGY: The Autoimmune blistering diseases Task Force of the European Academy of Dermatology and Venereology sought to update the guidelines for the management of BP based on new clinical information, and new evidence on diagnostic tools and interventions. The recommendations are either evidence-based or rely on expert opinion. The degree of consent among all task force members was included. RESULTS: Treatment depends on the severity of BP and patients' comorbidities. High-potency topical corticosteroids are recommended as the mainstay of treatment whenever possible. Oral prednisone at a dose of 0.5 mg/kg/day is a recommended alternative. In case of contraindications or resistance to corticosteroids, immunosuppressive therapies, such as methotrexate, azathioprine, mycophenolate mofetil or mycophenolate acid, may be recommended. The use of doxycycline and dapsone is controversial. They may be recommended, in particular, in patients with contraindications to oral corticosteroids. B-cell-depleting therapy and intravenous immunoglobulins may be considered in treatment-resistant cases. Omalizumab and dupilumab have recently shown promising results. The final version of the guideline was consented to by several patient organizations. CONCLUSIONS: The guidelines for the management of BP were updated. They summarize evidence- and expert-based recommendations useful in clinical practice.


Subject(s)
Dermatology , Pemphigoid, Bullous , Venereology , Adrenal Cortex Hormones/therapeutic use , Aged , Blister/drug therapy , Humans , Pemphigoid, Bullous/diagnosis , Pemphigoid, Bullous/drug therapy , Quality of Life
4.
J Eur Acad Dermatol Venereol ; 34(9): 1900-1913, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32830877

ABSTRACT

BACKGROUND: Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, pemphigus was almost always fatal. Due to its rarity, only few randomized controlled therapeutic trials are available. Recently, rituximab has been approved as first-line treatment for moderate and severe pemphigus vulgaris in Europe and the United States. OBJECTIVES: The Autoimmune blistering diseases Task Force of the European Academy of Dermatology and Venereology (EADV) has initiated a throughout update of the guideline for the management of patients with pemphigus. RESULTS: The guidelines for the management of pemphigus were updated, and the degree of consent among all task force members was included. The final version of the guideline was consented by the European Dermatology Forum (EDF) and several patient organizations.


Subject(s)
Dermatology , Guidelines as Topic , Pemphigus , Venereology , Academies and Institutes , Europe , Humans , Pemphigus/diagnosis , Pemphigus/drug therapy
5.
Opt Lett ; 44(13): 3314-3317, 2019 Jul 01.
Article in English | MEDLINE | ID: mdl-31259948

ABSTRACT

We report on the high detection sensitivity of a laser feedback interferometry scheme based on a terahertz frequency quantum cascade laser (QCL). We show that variations on the laser voltage induced by optical feedback to the laser can be resolved with the reinjection of powers as low as ∼-125 dB of the emitted power. Our measurements demonstrate a noise equivalent power of ∼1.4 pW/√Hz, although, after accounting for the reinjection losses, we estimate that this corresponds to only ∼1 fW/√Hz being coupled to the QCL active region.

9.
Clin Exp Dermatol ; 41(7): 723-9, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27480455

ABSTRACT

BACKGROUND: Cutaneous lupus erythematosus (CLE) is an autoimmune disease, often exacerbated by sun exposure. Patients are encouraged to avoid sun exposure, therefore predisposing them to vitamin D deficiency. AIM: To investigate the prevalence of and risk factors for vitamin D deficiency in patients with CLE. METHODS: Total serum 25-hydroxy vitamin D (25(OH)D) was measured in 87 consecutive patients with CLE and in 79 controls. Clinical characteristics, disease severity, medications used and lifestyle factors were analysed and compared to determine risk factors for inadequate (25(OH)D), defined as a serum (25(OH)D) level of < 20 µg/L. RESULTS: We found that 51% (n = 44) of the patients with CLE had 25(OH)D levels of < 20 µg/L compared with 73% (n = 58) of the controls (P < 0.01). No significant differences in (25(OH)D) levels were found between cases and controls with regard to age, sex, ethnicity, smoking, sun exposure, sunblock use or vitamin D supplementation. Treatment with antimalarials showed a statistically significant association with lower vitamin D levels. CONCLUSION: Low levels of vitamin D were found in both patients with CLE and controls. Despite being on vitamin D supplementation and living in an equatorial location, our Asian patients with CLE still had low levels of vitamin D. It is therefore important to ensure adequate vitamin D supplementation in patients with CLE, especially for those who are on antimalarial therapy.


Subject(s)
Asian People , Lupus Erythematosus, Cutaneous/blood , Lupus Erythematosus, Cutaneous/ethnology , Vitamin D Deficiency/epidemiology , Vitamin D/blood , Adult , Aged , Aged, 80 and over , Antimalarials/therapeutic use , Case-Control Studies , Dietary Supplements , Female , Humans , Life Style , Male , Middle Aged , Prevalence , Risk Factors , Singapore , Vitamin D Deficiency/diagnosis , Young Adult
10.
Osteoporos Int ; 27(8): 2577-83, 2016 08.
Article in English | MEDLINE | ID: mdl-27003892

ABSTRACT

UNLABELLED: Severe adverse drug reactions (ADR) of Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) in some patients receiving strontium ranelate have been reported, but the risk factors are unclear. We show that HLA-A*33:03 and B*58:01 are significantly associated with patients who developed SJS/TEN; and provide the first evidence that genetic risk factors are involved in strontium ranelate-associated SJS/TEN. INTRODUCTION: In this study, HLA as a genetic risk factor was assessed among osteoporotic patients prescribed with strontium ranelate that developed severe cutaneous adverse drug reactions (SCARs) compared with those who were tolerant. METHODS: Genomic DNA isolated from peripheral blood mononuclear cells (PBMCs) of patients was HLA typed using sequencing-based typing method to determine their HLA profiles. RESULTS: Osteoporotic patients who are currently on strontium ranelate were enrolled in the study (n = 76). Tolerant controls were defined as patients who received strontium ranelate for a minimum of 3 months (range 3 months to 8 years) with no reports of any cutaneous reactions as these reactions usually occur within the first 12 weeks after starting treatment. Retrospective cases of SJS/TEN were also identified (n = 5). The majority of the accrued samples were of Han Chinese descent: controls (n = 72) and cases (n = 4). All cases and controls were genotyped at four HLA genes, namely HLA-A, HLA-B, HLA-C, and HLA-DRB1. In comparing the samples of Han Chinese descent (72 controls and 4 cases), we found significant associations with HLA-A*33:03 (p = 0.002) and HLA-B*58:01 (p = 0.023). There was no significant association with any HLA-C or HLA-DRB1 alleles. CONCLUSIONS: This study reveals that the occurrence of SJS/TEN in Han Chinese patients receiving strontium ranelate is HLA associated. This has important clinical implications for understanding the underlying mechanisms for this ADR as well as evaluating the potential role of genetic pre-screening for osteoporotic patients who may be prescribed strontium ranelate.


Subject(s)
Anticonvulsants/adverse effects , Genetic Predisposition to Disease , HLA-B Antigens/genetics , Stevens-Johnson Syndrome/genetics , Thiophenes/adverse effects , Aged , Aged, 80 and over , Asian People/genetics , Case-Control Studies , China , Female , HLA-A Antigens/genetics , Humans , Leukocytes, Mononuclear , Male , Osteoporosis/drug therapy , Retrospective Studies
11.
Opt Lett ; 40(6): 950-3, 2015 Mar 15.
Article in English | MEDLINE | ID: mdl-25768154

ABSTRACT

We demonstrate an active phase-nulling scheme for terahertz (THz) frequency quantum cascade lasers (QCLs) under optical feedback, by active electronic feedback control of the emission frequency. Using this scheme, the frequency tuning rate of a THz QCL is characterized, with significantly reduced experimental complexity compared to alternative approaches. Furthermore, we demonstrate real-time displacement sensing of targets, overcoming the resolution limits imposed by quantization in previously implemented fringe-counting methods. Our approach is readily applicable to high-frequency vibrometry and surface profiling of targets, as well as frequency-stabilization schemes for THz QCLs.

12.
Opt Lett ; 40(6): 994-7, 2015 Mar 15.
Article in English | MEDLINE | ID: mdl-25768165

ABSTRACT

We demonstrate coherent three-dimensional terahertz imaging by frequency modulation of a quantum cascade laser in a compact and experimentally simple self-mixing scheme. Through this approach, we can realize significantly faster acquisition rates compared to previous schemes employing longitudinal mechanical scanning of a sample. We achieve a depth resolution of better than 0.1 µm with a power noise spectral density below -50 dB/Hz, for a sampling time of 10 ms/pixel.

13.
J Eur Acad Dermatol Venereol ; 29(8): 1539-44, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25491106

ABSTRACT

BACKGROUND: Fixed drug eruptions (FDE) are most commonly caused by antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs). The list of causative drugs changes with time and prescribing patterns but there has been no recent data on FDE seen in an outpatient setting in Singapore. OBJECTIVE: We aimed to evaluate the epidemiology, clinical features and causative drugs in patients with FDE in Singapore. METHODS: We performed a retrospective chart review of all patients seen with suspected FDE in the National Skin Centre, Singapore between 2008 and 2012. Using criteria adapted from the WHO-UMC causality assessment criteria, patients were classified into categories of definite (confirmed with patch test or drug provocation test), probable (causative drug identified based on patient's history), possible (clinically consistent but unable to identify causative drug) or unlikely FDE. RESULTS: We reviewed the charts of 126 patients who were seen for suspected FDE. Ten patients (7.0%) were classified as having definite FDE, 52 patients (41.3%) probable FDE, 61 patients (48.4%) possible FDE and three patients (2.4%) unlikely FDE. Clinical features were similar to those described in previous studies. Among the 62 patients with definite or probable FDE, etoricoxib was the most common cause (24 patients, 38.7%). Other common causes included paracetamol, other NSAIDs and doxycycline. Antihistamines caused FDE in three patients. CONCLUSION: Etoricoxib was the most frequent cause of FDE in our study. Other NSAIDs, paracetamol and doxycycline remain common causes of FDE but we caution that antihistamines, such as cetirizine, should also be considered.


Subject(s)
Drug Eruptions , Adolescent , Adult , Aged , Child , Child, Preschool , Drug Eruptions/diagnosis , Drug Eruptions/epidemiology , Drug Eruptions/etiology , Female , Humans , Male , Middle Aged , Retrospective Studies , Singapore/epidemiology , Young Adult
14.
Int J Tuberc Lung Dis ; 18(6): 725-9, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24903945

ABSTRACT

OBJECTIVE: To identify characteristics that differentiate lung disease due to non-tuberculous mycobacteria (NTM) from that due to pulmonary tuberculosis (PTB) in acid-fast bacilli (AFB) smear-positive patients with lung cavities. METHODS: From 2006 to 2012, 142 AFB smear- and culture-positive patients with lung cavities were identified at the Wonju Severance Christian Hospital, Wonju, Korea. Clinical and radiographic characteristics were compared between patients with NTM disease and PTB. RESULTS: Of 142 patients, 112 were diagnosed with PTB and 30 with NTM disease. Patients with NTM disease were older (62 vs. 49 years, P = 0.001), more likely to have had previous anti-tuberculosis treatment (18, 60.0% vs. 34, 30.6%; P = 0.001), more likely to have haemoptysis (9, 30.0% vs. 13, 11.9%; P = 0.022) and less likely to have consolidation on chest radiograph (20, 66.7% vs. 98, 87.5%; P = 0.007) than PTB patients. Multivariate analysis showed that age ≥65 years (OR 3.37, 95%CI 1.24-9.13, P = 0.010) and previous anti-tuberculosis treatment (OR 3.75, 95%CI 1.46-9.65, P = 0.006) were significantly associated with NTM disease. CONCLUSIONS: Cavitary patients with positive AFB smears and NTM or PTB had considerable overlapping clinical characteristics, although patients aged ≥65 years or with a previous history of anti-tuberculosis treatment were more likely to have NTM.


Subject(s)
Lung/microbiology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium tuberculosis/isolation & purification , Nontuberculous Mycobacteria/isolation & purification , Respiratory Tract Infections/microbiology , Tuberculosis, Pulmonary/microbiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Antitubercular Agents/therapeutic use , Chi-Square Distribution , China , Diagnosis, Differential , Female , Humans , Logistic Models , Lung/diagnostic imaging , Lung/drug effects , Male , Middle Aged , Multivariate Analysis , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium tuberculosis/drug effects , Odds Ratio , Predictive Value of Tests , Radiography , Respiratory Tract Infections/diagnosis , Risk Factors , Sputum/microbiology , Time Factors , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/drug therapy , Young Adult
15.
Opt Lett ; 39(9): 2629-32, 2014 May 01.
Article in English | MEDLINE | ID: mdl-24784063

ABSTRACT

We propose a terahertz (THz)-frequency synthetic aperture radar imaging technique based on self-mixing (SM) interferometry, using a quantum cascade laser. A signal processing method is employed which extracts and exploits the radar-related information contained in the SM signals, enabling the creation of THz images with improved spatial resolution. We demonstrate this by imaging a standard resolution test target, achieving resolution beyond the diffraction limit.

16.
Br J Dermatol ; 170(6): 1319-26, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24372558

ABSTRACT

BACKGROUND: Bullous pemphigoid (BP) is the most common autoimmune-mediated subepidermal blistering skin disease and is associated with significant morbidity and mortality. OBJECTIVES: To determine the 3-year mortality rate, risk factors and causes of death in patients with BP in Singapore, compared with the general population. METHODS: We conducted a retrospective cohort study of all newly diagnosed patients with BP seen at the National Skin Centre from 1 April 2004 to 31 December 2009. Demographic and clinical data on comorbidities and treatment were recorded. Mortality information was obtained from the National Registry of Diseases. RESULTS: In total 359 patients were included in our study. The 1-, 2-, 3-year mortality rates were 26·7%, 38·4% and 45·7%, respectively. The 3-year standardized mortality risk for patients with BP was 2·74 (95% confidence interval 2·34-3·19) times higher than for the age- and sex-matched general population. Parkinson disease, heart failure and chronic renal disease were associated with increased mortality, while combination treatment with low-to-moderate-dose corticoste-roids and immunomodulatory agents such as doxycycline and/or nicotinamide was associated with lower mortality. Overall, infections were the most common cause of death (59·8%), with the main causes of death being pneumonia (42·7%), cardiovascular disease (14·6%) and stroke (11·6%). CONCLUSIONS: This study confirms an increased 3-year mortality rate for patients with BP in Singapore. Risk factors for increased mortality include medical comorbidities, especially neurological, cardiac and renal diseases. Treatment with combination therapy, including the use of low-to-moderate-dose corticosteroid, appeared to decrease mortality risk in patients with BP.


Subject(s)
Pemphigoid, Bullous/mortality , Adult , Age Distribution , Age of Onset , Aged , Aged, 80 and over , Epidemiologic Methods , Female , Humans , Male , Middle Aged , Sex Distribution , Singapore/epidemiology
17.
Br J Dermatol ; 169(6): 1304-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24007192

ABSTRACT

BACKGROUND: Toxic epidermal necrolysis (TEN) is a severe cutaneous adverse drug reaction with a mortality of 40%. Intravenous immunoglobulin (IVIg) is widely used as a specific treatment for this reaction, although evidence of its benefit is conflicting. OBJECTIVES: We sought to evaluate whether the use of IVIg improved mortality in patients with Stevens-Johnson syndrome (SJS)/TEN overlap and TEN. METHODS: We retrospectively analysed data for 64 patients with SJS/TEN overlap and TEN who were treated with IVIg at a single referral centre. The primary outcome analysed was in-hospital mortality. Predicted mortality was calculated based on severity-of-illness score for TEN (SCORTEN) values. Secondary analyses of survival based on IVIg dosages and prior corticosteroid exposure were also performed. RESULTS: There were 28 cases of SJS/TEN overlap and 36 cases of TEN, with a mean SCORTEN value of 2·6. The mean dose of IVIg given was 2·4 g kg(-1) and the mean delay from the onset of epidermal detachment to administration of IVIg was 3·2 days. There were 20 deaths (31%) in our cohort. The standardized mortality rate was 1·10 (95% confidence interval 0·62-1·58). Subgroup analysis comparing survivors and nonsurvivors showed a higher SCORTEN in nonsurvivors (3·4 vs. 2·2). There were no differences with regard to the dosage, delay and duration of IVIg administration. When stratified according to dosage, there was no mortality difference between patients who receive high-dose (≥ 3 g kg(-1) ) vs. low-dose (< 3 g kg(-1) ) IVIg. CONCLUSIONS: This study shows that the use of IVIg does not yield survival benefits in SJS/TEN overlap and TEN, even when corrected for IVIg dosages.


Subject(s)
Immunoglobulins, Intravenous/therapeutic use , Immunologic Factors/therapeutic use , Stevens-Johnson Syndrome/drug therapy , Adrenal Cortex Hormones/therapeutic use , Dose-Response Relationship, Drug , Female , Humans , Male , Middle Aged , Retrospective Studies , Stevens-Johnson Syndrome/ethnology , Stevens-Johnson Syndrome/mortality
18.
Intern Med J ; 42 Suppl 5: 68-70, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23035685

ABSTRACT

Interventional cardiologists from China first arrived at the Epworth Hospital in Melbourne for training in percutaneous transluminal coronary angioplasty in 1988. Percutaneous transluminal coronary angioplasty was initially performed in China in 1981 in Xian. In those days, angioplasty balloons and catheters that were brought into China mainly by foreign experts were used repeatedly until they were broken. Dr. Antonio Colombo was invited to visit Beijing, China, in 1998 to demonstrate coronary stenting at the Chaoyang Hospital. By 2010, more than 300,000 cases of percutaneous coronary interventions (PCIs) had been performed throughout China. If the current rate of PCIs per population in the West was to be applied in China, more than 4 million PCIs should have been performed annually.


Subject(s)
Cardiology/education , Cooperative Behavior , Physicians , Cardiology/methods , China , Humans , Victoria
20.
Clin Exp Dermatol ; 37(4): 374-8, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22300247

ABSTRACT

Amicrobial pustulosis associated with autoimmune disease (APAD) is a rare clinical condition, characterized by relapsing pustular eruption, affecting mainly the skin folds. Almost all previously described cases were young women with varying underlying autoimmune diseases. We report a 36-year-old woman with the interesting triad of APAD, Sjögren syndrome and IgA nephropathy. Her rashes responded to oral prednisolone and cyclophosphamide.


Subject(s)
Autoimmune Diseases/complications , Glomerulonephritis, IGA/complications , Sjogren's Syndrome/complications , Skin Diseases, Vesiculobullous/complications , Adrenal Cortex Hormones/therapeutic use , Adult , Female , Humans , Immunosuppressive Agents/therapeutic use , Skin Diseases, Vesiculobullous/immunology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL